Role of genetic polymorphisms in NFKB-mediated inflammatory pathways in response to primary chemoradiation therapy for rectal cancer

International Journal of Radiation Oncology Biology Physics

Volumn 90, Issue 3, 2014, Pages 595-602

  Dzhugashvili, Maia ^a,b   Luengo Gil, Ginés ^a   García, Teresa ^a   González Conejero, Rocío ^a   Conesa Zamora, Pablo ^c   Escolar, Pedro Pablo ^c   Calvo, Felipe ^d   Vicente, Vicente ^a   Ayala De La Peña, Francisco ^a  

^a HOSPITAL MORALES MESEGUER   (Spain)

^b Department of Radiation Oncology Madrid Oncology Institute (Group IMO)   (Spain)

^c University Hospital Santa Lucia   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMORADIOTHERAPY; GENES; LOGISTIC REGRESSION; MULTIVARIANT ANALYSIS; PATHOLOGY; SENSITIVITY ANALYSIS;

CHEMORADIATION THERAPIES; COMBINED MODALITY TREATMENT; DISEASE FREE SURVIVAL; GENETIC POLYMORPHISMS; LOCALLY ADVANCED RECTAL CANCERS; LOGISTIC REGRESSION MODELS; MULTI VARIATE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISMS;

DISEASES;

CAPECITABINE; FLUOROURACIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OXALIPLATIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DEOXYCYTIDINE; IL1B PROTEIN, HUMAN; INTERLEUKIN 1BETA; OXIPLATIN; PLATINUM COMPLEX; PTGS1 PROTEIN, HUMAN; PTGS2 PROTEIN, HUMAN; PYRIDINE DERIVATIVE;

ADVANCED CANCER; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ENTERITIS; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PARALYTIC ILEUS; PERITONITIS; POSTOPERATIVE COMPLICATION; PREOPERATIVE COMPLICATION; PRIMARY CHEMORADIATION THERAPY; PROCTITIS; RADIATION DOSE; RECTUM CANCER; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT DURATION; TREATMENT OUTCOME; TUMOR LOCALIZATION; TUMOR VOLUME; ADULT; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; COMPUTER ASSISTED RADIOTHERAPY; GENETICS; INFLAMMATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES; RECTAL NEOPLASMS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DEOXYCYTIDINE; ENTERITIS; FEMALE; FLUOROURACIL; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; NF-KAPPA B; ORGANOPLATINUM COMPOUNDS; POLYMORPHISM, GENETIC; PROCTITIS; PYRIDINES; RADIATION TOLERANCE; RADIOTHERAPY, CONFORMAL; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84907973585     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.06.060     Document Type: Article

References (31)

1. R. Sauer, H. Becker, and W. Hohenberger Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731 1740
2. J.F. Bosset, L. Collette, and G. Calais Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 2006 1114 1123
3. A. Deorukhkar, and S. Krishnan Targeting inflammatory pathways for tumor radiosensitization Biochem Pharmacol 80 2010 1904 1914
4. T.K. Hei, H. Zhou, and Y. Chai Radiation induced non-targeted response: Mechanism and potential clinical implications Curr Mol Pharmacol 4 2011 96 105
5. B.H. O'Neil, W.K. Funkhouser, and B.F. Calvo Nuclear factor kappa-light chain-enhancer of activated B cells is activated by radiotherapy and is prognostic for overall survival in patients with rectal cancer treated with preoperative fluorouracil-based chemoradiotheraphy Int J Radiat Oncol Biol Phys 80 2011 705 711
6. S.K. Sandur, A. Deorukhkar, and M.K. Pandey Curcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF-kappaB activity Int J Radiat Oncol Biol Phys 75 2009 534 542
7. A. Debucquoy, L. Goethals, and L. Libbrecht Molecular and clinico-pathological markers in rectal cancer: A tissue micro-array study Int J Colorectal Dis 24 2009 129 138
8. Y.F. Zou, F.L. Yuan, and X.L. Feng Association between NFKB1 -94ins/delATTG promoter polymorphism and cancer risk: A meta-analysis Cancer Invest 29 2011 78 85
9. S.S. Lo, J.H. Chen, and C.W. Wu Functional polymorphism of NFKB1 promoter may correlate to the susceptibility of gastric cancer in aged patients Surgery 145 2009 280 285
10. V. Andersen, J. Christensen, and K. Overvad Polymorphisms in NFkB, PXR, LXR and risk of colorectal cancer in a prospective study of Danes BMC Cancer 10 2010 484
11. K. Riemann, L. Becker, and H. Struwe No association of the NFKB1 insertion/deletion promoter polymorphism with survival in colorectal and renal cell carcinoma as well as disease progression in B-cell chronic lymphocytic leukemia Pharmacogenet Genom 16 2006 783 788
12. U. Vogel, S. Segel, and C. Dethlefsen Associations between COX-2 polymorphisms, blood cholesterol and risk of acute coronary syndrome Atherosclerosis 209 2010 155 162
13. D.G. Cox, J.B. Crusius, and P.H. Peeters Haplotype of prostaglandin synthase 2/cyclooxygenase 2 is involved in the susceptibility to inflammatory bowel disease World J Gastroenterol 11 2005 6003 6008
14. D. Iglesias, N. Nejda, and M.M. Azcoita Effect of COX2 -765G>C and c.3618A>G polymorphisms on the risk and survival of sporadic colorectal cancer Cancer Causes Control 20 2009 1421 1429
15. A.E. Coghill, P.A. Newcomb, and E.M. Poole Genetic variation in inflammatory pathways is related to colorectal cancer survival Clin Cancer Res 17 2011 7139 7147
16. B. He, Y. Zhang, and Y. Pan Interleukin 1 beta (IL1B) promoter polymorphism and cancer risk: evidence from 47 published studies Mutagenesis 26 2011 637 642
17. J.D. Schoenfeld, D.N. Margalit, and J.L. Kasperzyk A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer Clin Cancer Res 19 2013 1612 1619
18. M.A. Hildebrandt, R. Komaki, and Z. Liao Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer PLoS One 5 2010 e12402
19. S.H. Petersen, H. Harling, and L.T. Kirkeby Postoperative adjuvant chemotherapy in rectal cancer operated for cure Cochrane Database Syst Rev 3 2012 CD004078
20. M.A. Schirmer, C.P.N. Mergler, and M. Rave-Fränk Acute toxicity of radiochemotherapy in rectal cancer patients: A risk particularly for carriers of the TGFB1 Pro25 variant Int J Radiat Oncol Biol Phys 83 2012 149 157
21. M. Vieth, P. Quirke, and R. Lambert Annex to Quirke, et al. Quality assurance in pathology in colorectal cancer screening and diagnosis: Annotations of colorectal lesions Virchows Arch 458 2011 21 30
22. I.J. Park, Y.N. You, and A. Agarwal Neoadjuvant treatment response as an early response indicator for patients with rectal cancer J Clin Oncol 30 2012 1770 1776
23. B. Fontaine-Bisson, T.M.S. Wolever, and P.W. Connelly NF-kappaB -94Ins/Del ATTG polymorphism modifies the association between dietary polyunsaturated fatty acids and HDL-cholesterol in two distinct populations Atherosclerosis 204 2009 465 470
24. X. Sole, E. Guino, and J. Valls SNPStats: A web tool for the analysis of association studies Bioinformatics 22 2006 1928 1929
25. H.A. Wolff, J. Gaedcke, and K. Jung High-grade acute organ toxicity during preoperative radiochemotherapy as positive predictor for complete histopathologic tumor regression in multimodal treatment of locally advanced rectal cancer Strahlenther Onkol 186 2010 30 35
26. G.C. Barnett, C.E. Coles, and R.M. Elliott Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: A prospective analysis study Lancet Oncol 13 2012 65 77
27. J. Garcia-Aguilar, Z. Chen, and D.D. Smith Identification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancer Ann Surg 254 2011 486 492 discussion 492-493
28. M.J. Lamas, G. Duran, and A. Gomez X-ray cross-complementing group 1 and thymidylate synthase polymorphisms might predict response to chemoradiotherapy in rectal cancer patients Int J Radiat Oncol Biol Phys 82 2012 138 144
29. A.S. Karban, T. Okazaki, and C.I.M. Panhuysen Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis Hum Mol Genet 13 2004 35 45
30. C. Rödel, P. Martus, and T. Papadoupolos Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer J Clin Oncol 23 2005 8688 8696
31. A. Debucquoy, S. Roels, and L. Goethals Double blind randomized phase II study with radiation+5-fluorouracil+/-celecoxib for resectable rectal cancer Radiother Oncol 93 2009 273 278